Fla. Admin. Code R. 2ER25-1
Addition of 7-Hydroxymitragynine (methyl (E)-2[(2S,3S,7aS,12bS)-3-ethyl-7a-hydroxy-8-methoxy-2,3,4,6,7,12b-hexahydro-1H-indolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate) concentrated at a level above 1 percent by total weight TO SCHEDULE I, SUBSECTION 893.03(1)(a), F.S. (Superseded by 2ER25-2)
Effective Aug 12, 2025Rulemaking Authority 893.035 FS. Law Implemented 893.03, 893.035 FS.Department of Legal Affairs
2ER25-1 Addition of 7-Hydroxymitragynine (methyl (E)-2[(2S,3S,7aS,12bS)-3-ethyl-7a-hydroxy-8-methoxy-2,3,4,6,7,12b-hexahydro-1H-indolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate) concentrated at a level above 1 percent by total weight TO SCHEDULE 1, SUBSECTION 893.03(1)(a), F.S.
- (1) Under the authority of Section 893.035, F.S., the following substance is hereby added to Schedule I, subsection 893.03(1)(a), F.S.: 7-Hydroxymitragynine (methyl (E)-2[(2S,3S,7aS,12bS)-3-ethyl-7a-hydroxy-8-methoxy-2,3,4,6,7,12b-hexahydro-1H-indolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate) concentrated at a level above 1 percent by total weight. This designation does not apply to mitragynine.
(2) All provisions of Chapter 893, F.S., applicable to controlled substances listed in Schedule I shall be applicable to the substances listed in subsection (1) above.
Rulemaking Authority 893.035 FS. Law Implemented 893.03, 893.035 FS. History – New 8-12-25, Superseded by 2ER25-2, 8-19-25.